Short-Term Stocks With Analyst Stock Upgrades and Upside Potential

 Bullish.Bets
 
  Bullish.Bets
 
Follow  Message
 
 
 
Bullish.Bets focuses on stocks poised for explosive moves up or down, scanning volatility, catalysts, and sentiment shifts to uncover high-impact trading opportunities
 

•  14 Jan 2026
 

•   APLD  
   
  +0.23%
•   AXSM  
   
  +0.19%
•   BRCC  
   
  -3.92%
•   C  
   
  +0.44%
•   CNCK  
   
  +0.79%

$BRCC – Upside 160.20%
Black Rifle Coffee is trading near its 52-week low while analysts raised the average target to $2.55. With expectations washed out and volume holding steady, this is a classic high-risk turnaround setup where even small operational improvements could drive an outsized rebound.

$GWH – Upside 99.44%
ESS Tech offers nearly double upside to its revised target, but the stock remains in a clear downtrend. Analyst optimism is improving faster than price action, making this more suitable for traders waiting for a confirmed trend reversal.

$VNCE – Upside 86.11%
Vince Holding is basing sideways with a meaningful target hike. The stock is holding above key lows, and stabilization near short-term averages suggests a potential breakout if retail sentiment improves.

$ORKA – Upside 80.78%
Oruka Therapeutics stands out with a strong uptrend, healthy RSI, and solid analyst confidence. This is a momentum-friendly biotech name where upside is supported by both technicals and fundamentals.

$CNCK – Upside 68.87%
Coincheck Group shows sizable upside on paper, but the prevailing downtrend and weak volume signal hesitation. A shift in crypto sentiment could change the picture quickly, but confirmation is needed.

$GLSI – Upside 47.49%
Greenwich LifeSciences remains in a firm uptrend with elevated momentum. While part of the move is already priced in, the remaining upside keeps it relevant for trend-following traders.

$APLD – Upside 40.21%
Applied Digital combines strong liquidity, heavy volume, and a clean uptrend. Analysts still see meaningful upside, making this one of the more attractive short-term continuation setups.

$DSGN – Upside 34.35%
Design Therapeutics is quietly trending higher with improving analyst targets. Low volume adds volatility, but the structure supports gradual upside if biotech sentiment stays constructive.

$GPCR – Upside 23.80%
Structure Therapeutics has strong momentum and elevated RSI. Upside is more moderate now, but the trend remains clearly intact.

$NEOG – Upside 21.96%
Neogen saw a sharp target increase, yet the stock is already extended. Upside exists, though near-term consolidation would be healthy before the next leg higher.

$EKSO – Upside 21.58%
Ekso Bionics is trending higher but trading closer to its target. Pullbacks would offer better risk-reward than chasing strength.

$KLAC – Upside 18.00%
KLA Corporation continues to trend higher with analyst support, but upside is more measured after a strong multi-month run.

$AXSM – Upside 17.82%
Axsome Therapeutics remains in a solid uptrend with steady analyst confidence. Upside is incremental, favoring disciplined dip buyers.

$DIBS – Upside 17.63%
1stdibs is in an orderly uptrend with reasonable upside. Liquidity is modest, but sentiment is improving steadily.

$FLNT – Upside 17.54%
Fluent received a notable target increase, though price action remains sideways. A breakout would be needed to unlock the projected upside.

$C – Upside 17.41%
Citigroup offers steady upside within a sideways base. This is a lower-volatility play tied more to macro stability than momentum.

$EU – Upside 12.84%
enCore Energy shows limited upside with a neutral trend. The market appears to be waiting for clearer catalysts.

$DVN – Upside 12.00%
Devon Energy remains fundamentally supported with a constructive trend, but upside is modest and more suitable for conservative traders.

View All Headlines